Hanover, NH · Founded 2000 · Privately Held (backing)
Developer of a gene therapy platform designed for a rare genetic eye disorder that typically presents with severe progressive visual impairment. Hubble Therapeutics is based in Hanover, NH and was founded in 2000. It has raised $20.3 million across 1 recorded round; the latest was a $9.8 million early-stage round in Oct 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$20.3M
Last round
Early Stage VC
Oct 2024
Team — not yet on record
No current team members for Hubble Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Hubble Therapeutics with a free Private Market View account
·Watch Hubble Therapeutics: the Monday email on marks, rounds and moves
